XML 34 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant Accounting Policies (Details) (USD $)
Share data in Millions, unless otherwise specified
3 Months Ended 9 Months Ended 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Mar. 31, 2012
Canadian Pharmacy [Member]
Acquisition Costs $ (3,830,000) $ 6,718,000 $ 396,000 $ 10,939,000  
Restructuring Charges 11,046,000 0 11,046,000 0  
charges relating to business disposition (7,680,000) 0 (1,777,000) 0  
Separation, Benefit Plan Termination and Related Costs 5,500,000 0 21,000,000 0  
Debt related costs 0 0 35,092,000 0  
Subtotal - Other miscellaneous charges 5,036,000 6,718,000 65,757,000 10,939,000  
Goodwill, Impairment Loss         5,900,000
Common Stock Repurchase Program: [Abstract]          
Authorized Amount of Repurchase of Outstanding Common Stock 350,000,000        
Shares Repurchased (in shares)     3.4    
Aggregate Cost of Shares repurchased     111,000,000    
cumulative value of shares repurchased through stock repurchase program 352,000,000   352,000,000    
cumulative common stock repurchased through repurchase program 12.6   12.6    
Remaining Authorized Repurchase Amount     $ 498,000,000